|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C65.1 |
Malignant neoplasm of right renal pelvis
|
C651 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 52.31%
|
27.89%
|
8.98%
|
4.14%
|
2.34%
|
1.34%
|
0.92%
|
0.57%
|
0.44%
|
0.33%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C65.1*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,746
|
1,746
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,583
|
1,583
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,421
|
1,429
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,312
|
1,322
|
|
J2405
|
ONDANSETRON HCL INJECTION |
795
|
3,871
|
|
J3010
|
FENTANYL CITRATE INJECTION |
794
|
1,170
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
726
|
50,726
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
720
|
19,457
|
|
C1769
|
GUIDE WIRE |
626
|
1,126
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
612
|
4,915
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
561
|
739
|
|
96413
|
CHEMO IV INFUSION 1 HR |
532
|
532
|
|
52354
|
CYSTOURETERO W/BIOPSY |
504
|
504
|
|
80048
|
METABOLIC PANEL TOTAL CA |
501
|
502
|
|
52332
|
CYSTOSCOPY AND TREATMENT |
472
|
472
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
457
|
1,761
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
449
|
1,413
|
|
C2617
|
STENT, NON-COR, TEM W/O DEL |
424
|
445
|
|
83735
|
ASSAY OF MAGNESIUM |
414
|
416
|
|
C1758
|
CATHETER, URETERAL |
411
|
513
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C65.1 related to the following DRG Codes:
656-658
686-688
|
